TY  - GEN
AU  - Scherl,Ellen J
AU  - Pruitt,Ronald
AU  - Gordon,Glenn L
AU  - Lamet,Mark
AU  - Shaw,Audrey
AU  - Huang,Shirley
AU  - Mareya,Shadreck
AU  - Forbes,William P
TI  - Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study
SN  - 1572-0241
PY  - 2009///0623
KW  - Adult
KW  - Aged
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - administration & dosage
KW  - Colitis, Ulcerative
KW  - complications
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Gastrointestinal Hemorrhage
KW  - etiology
KW  - Humans
KW  - Male
KW  - Mesalamine
KW  - Middle Aged
KW  - Phenylhydrazines
KW  - Prospective Studies
KW  - Rectum
KW  - Severity of Illness Index
KW  - Sigmoidoscopy
KW  - Tablets
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/ajg.2009.83
ER  -